Project Grant 60NANB24D286
Award Date
10/15/24
Completion Date
10/15/25
Dollars Obligated
$65K
Federal Agency
National Institute of Standards and Technology
Federal Grant Program
11.609
Assistance Type
Project Grant
Place of Performance
Potomac, MD 20850, USA
Similar Awards
This $586,936 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a low-cost, disposable urine test strip that can rapidly and quantitatively measure substance use disorder (SUD) medication drugs and their metabolites. The award recipient, Vitan-Biotech LLC, will create a point-of-use lateral flow assay (LFA) test strip that leverages innovative signal amplification technology to...
This $1,200,000 Cooperative Agreement award, issued on September 1, 2024 by the Executive Office of the President's Office of the National Drug Control Policy (ONDCP) under CFDA Program 95.007 "Research and Data Analysis", will support the National Association of County and City Health Officials (NACCHO) in implementing overdose response strategy pilot projects at the intersection of public health and public safety. The goal of this project is to conduct research and data analysis to...
This federal Project Grant award of $306,872 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the validation of a novel measurement platform developed by Xcellassay, Inc. to identify individuals, particularly youths, using anabolic androgenic steroids (AAS). The proposed technology utilizes a high-throughput androgen receptor (AR) bioassay to quantify androgen levels in small blood samples, along with a proprietary...
This Cooperative Agreement award of $818,486 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to advance the development and validation of the Stimulant Use Disorder Severity Scale (STUDSS) as a qualified Clinical Outcome Assessment (COA) and Drug Development Tool (DDT) with the U.S. Food and Drug Administration (FDA). The project, conducted by Yale University, involves three sequential stages: 1) submitting a Letter of...
This Cooperative Agreement award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and validate a novel patient-reported outcome measure of substance-related consequences for use in substance use disorder (SUD) treatment trials. The $352,064 award, effective from August 1, 2025 to July 31, 2027, will be executed by the Mclean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), funded under the Alcohol Research Programs (CFDA 93.273), provides $399,293 to Echelon Biosciences Inc. to develop a prototype rapid point-of-care phosphatidylethanol (PEth) competitive lateral flow immunoassay. PEth is considered the most reliable long-term biomarker for detecting alcohol consumption, but current testing methods are costly and have slow turnaround times. The goal of this Phase I...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding the development of a comprehensive fentanyl testing device by Taesun, LLC. The $305,369 award aims to create an integrated device that simplifies the process of fentanyl detection, making it more accessible and user-friendly for use in high-risk environments. The device will combine multiple testing steps, such as crushing, measuring, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $400,000 to Mountainpass Technology LLC to develop, refine, and evaluate a customized version of their "MyTrials" integrated remote biomarker capture system for decentralized clinical trials (DCTs) focused on substance use disorders (SUDs). The project aims to address key methodological limitations of DCTs for SUDs by creating a product...
The National Institute on Drug Abuse (NIDA) awarded a $386,452 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The grant supports the development of a rapid fingerstick diagnostic test for opioid and stimulant use disorders. This project aims to address the escalating public health crisis of opioid and stimulant overdose deaths in the United States, which reached over 107,000 in...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $289,620 to Oregon State University to develop a personalized therapeutic drug monitoring (PTDM) system. The key products and services to be delivered under this 4-year project include: A personalized drug titration pharmacokinetic (PK) model to account for varying drug...